Nirmal J - Search Results

1

Stability enhancement of Amphotericin B using 3D printed biomimetic polymeric corneal patch to treat fungal infections.

Kailasam V, Hiremath MS, Sudharsan P, Nagarjuna V, Garg P, Nirmal J. Kailasam V, et al. Among authors: nirmal j. Int J Pharm. 2024 Dec 28;670:125149. doi: 10.1016/j.ijpharm.2024.125149. Online ahead of print. Int J Pharm. 2024. PMID: 39736279

2

Ocular delivery of Amphotericin B: current challenges and future perspectives.

Kailasam V, Sai Veda Koduganti S, Dasgupta O, Garg P, Nirmal J. Kailasam V, et al. Among authors: nirmal j. Expert Opin Drug Deliv. 2024 Dec;21(12):1793-1805. doi: 10.1080/17425247.2024.2420750. Epub 2024 Oct 27. Expert Opin Drug Deliv. 2024. PMID: 39436406 Review.

3

Organic cation transporter 1 in the lacrimal gland facilitates the entry of systemic drugs causing ocular surface toxicity.

Malani M, Shah M, Velpandian T, Nirmal J. Malani M, et al. Among authors: nirmal j. Exp Eye Res. 2024 Nov;248:110098. doi: 10.1016/j.exer.2024.110098. Epub 2024 Sep 14. Exp Eye Res. 2024. PMID: 39284508

4

Complement Cascade 8 - Alpha and Calpain-2 in Extracellular Vesicles of Human Vitreous as Biomarkers of Infectious Endophthalmitis.

Rudraprasad D, K V, Nirmal J, Ali MH, Joseph J. Rudraprasad D, et al. Among authors: nirmal j. Transl Vis Sci Technol. 2024 May 1;13(5):14. doi: 10.1167/tvst.13.5.14. Transl Vis Sci Technol. 2024. PMID: 38767905 Free PMC article.

5

Exploring the Therapeutic Potential of Anti-VEGF Drugs for the Management of Diabetic Retinopathy: An Overview.

Khandelwal A, Gowthamarajan K, Nirmal J, Ponnusankar S. Khandelwal A, et al. Among authors: nirmal j. Curr Diabetes Rev. 2024 Apr 16. doi: 10.2174/0115733998294968240405091023. Online ahead of print. Curr Diabetes Rev. 2024. PMID: 38629377

6

Nanomicelles empower natamycin in treating fungal keratitis: An in vitro, ex vivo and in vivo study.

Sathe P, Kailasam V, Nagarjuna V, Sharma H, Velpandian T, Garg P, Nirmal J. Sathe P, et al. Among authors: nirmal j. Int J Pharm. 2024 May 10;656:124118. doi: 10.1016/j.ijpharm.2024.124118. Epub 2024 Apr 12. Int J Pharm. 2024. PMID: 38615806

7

A promising 'single' and 'dual' drug-nanocomposite enriched contact lens for the management of glaucoma in response to the tear fluid enzyme.

Kumara BN, Velmurugan K, Ghate MV, Shambhu R, Nirmal J, Prasad KS. Kumara BN, et al. Among authors: nirmal j. J Mater Chem B. 2024 Feb 28;12(9):2394-2412. doi: 10.1039/d3tb02624h. J Mater Chem B. 2024. PMID: 38349383

8

Combination of self-assembling system and N,O-carboxymethyl chitosan improves ocular residence of anti-glaucoma drug.

Kailasam V, Kumara BN, Prasad KS, Nirmal J. Kailasam V, et al. Among authors: nirmal j. Eur J Pharm Biopharm. 2024 Apr;197:114208. doi: 10.1016/j.ejpb.2024.114208. Epub 2024 Feb 7. Eur J Pharm Biopharm. 2024. PMID: 38336235

9

Carboxylated nanofibrillated cellulose empowers moxifloxacin to overcome Staphylococcus aureus biofilm in bacterial keratitis.

Malani M, Thodikayil AT, Saha S, Nirmal J. Malani M, et al. Among authors: nirmal j. Carbohydr Polym. 2024 Jan 15;324:121558. doi: 10.1016/j.carbpol.2023.121558. Epub 2023 Nov 7. Carbohydr Polym. 2024. PMID: 37985120

10

Development of mucoadhesive Timolol loaded chitosan-nanocomposite to treat glaucoma.

Kumara BN, Shambhu R, Shim YB, Nirmal J, Prasad KS. Kumara BN, et al. Among authors: nirmal j. Int J Biol Macromol. 2023 Dec 31;253(Pt 3):126917. doi: 10.1016/j.ijbiomac.2023.126917. Epub 2023 Sep 15. Int J Biol Macromol. 2023. PMID: 37716661

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters